DocMorris AG (DOCM)

Currency in CHF
10.97
+0.07(+0.64%)
Delayed Data·
Advertisement
DOCM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.5711.05
52 wk Range
3.9211.25
Key Statistics
Bid/Ask
10.95 / 10.98
Prev. Close
10.9
Open
11.04
Day's Range
10.57-11.05
52 wk Range
3.92-11.25
Volume
120.45K
Average Volume (3m)
358.04K
1-Year Change
64.7147%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DOCM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11.15
Upside
+1.64%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

DocMorris AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

3 Buy
6 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 11.15
(+1.64% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Jefferies
Hold11.00+0.27%9.50Downgrade26/08/2026
Deutsche Bank
Buy12.50+13.95%11.50Maintain24/08/2026
UBS
Hold11.00+0.27%10.70Maintain20/08/2026
Berenberg
Hold10.15-7.47%4.45Maintain20/08/2026
Barclays
Hold12.00+9.39%8.00Maintain21/07/2026

DocMorris AG Earnings Call Summary for Q2/2026

  • DocMorris reported H1 2026 revenue growth of 13.4% in local currency, driven by 38.3% Rx revenue increase and 71% digital services jump.
  • Adjusted EBITDA margin improved 350 basis points to -1.8%, though shares fell 6.02% to $9.05 despite raised guidance and strong results.
  • Company raised 2026 revenue growth guidance to 9-13% from 3-12%; narrowed expected EBITDA loss to CHF 10-17.5M from CHF 10-25M.
  • Management reaffirmed EBITDA breakeven target during 2026; AI-First strategy expected to deliver CHF 50M+ annual savings by end of 2027.
  • Key risks include continued cash burn of $114M, negative profitability, and execution uncertainty around co-payment strategy for 2027.
Last Updated: 19/08/2026, 11:22
Read Full Transcript

Earnings

Latest Release
19/08/2026
EPS / Forecast
-1.10 / --
Revenue / Forecast
295.2M / 286.05M
EPS Revisions
Last 90 days

Compare DOCM to Peers and Sector

Metrics to compare
DOCM
Peers
Sector
Relationship
P/E Ratio
−4.4x−3.1x11.5x
PEG Ratio
−0.080.010.03
Price/Book
1.5x1.4x1.5x
Price / LTM Sales
0.5x0.6x0.9x
Upside (Analyst Target)
1.2%14.8%22.7%
Fair Value Upside
Unlock15.9%12.7%Unlock

DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. The company offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insurers, and health institutions. It sells its products to online mail-order pharmacies, and private individuals under the DocMorris, PromoFarma by DocMorris, and TeleClinic brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
9.42M18.66%103.61M
Other Institutional Investors
21.47M42.52%236.15M
Public Companies & Retail Investors
19.60M38.82%215.61M
Total
50.49M100.00%555.38M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Pelion S.A.15.58%7,867,38086,541
UBS Asset Management AG10.18%5,141,51856,557

People Also Watch

91.80
VONN
-1.50%
18.68
RSGN
-2.30%
29.26
SRAIL
-1.94%
88.55
CMBN
-0.11%
15.60
EFGN
-2.50%

FAQ

What Is the DocMorris (Switzerland: DOCM) Share Price Today?

The DocMorris stock price today is 10.97 CHF.

What Stock Exchange Does DocMorris (DOCM) Trade On?

DocMorris is listed and trades on the Switzerland Stock Exchange.

What Is the Ticker (Stock Symbol) for DocMorris?

The stock symbol (also called a 'ticker') for DocMorris is "DOCM."

What Is the Current DocMorris Market Capitalisation?

As of today, DocMorris (Switzerland: DOCM) market cap is 548.81M CHF.

What Is DocMorris's (DOCM) Earnings Per Share (TTM)?

The DocMorris EPS is currently -2.61 (Trailing Twelve Months).

When Is the Next DocMorris Earnings Date?

DocMorris's next earnings report will be released on 15/10/2026.

Is DOCM a Buy or Sell From a Technical Analyst Perspective?

Based on today's DocMorris moving averages and other technical indicators, the daily buy/sell signal for DOCM stock is Strong Buy.

How Many Times Has DocMorris Stock Split?

DocMorris has split 2 times. (See the DOCM stock split history page for full effective split date and price information.)

How Many Employees Does DocMorris Have?

DocMorris has 1337 employees, based on their latest Companies House report.

What is the current trading status of DocMorris (Switzerland: DOCM)?

As of 01/09/2026, DocMorris (DOCM) is trading at a share price of 10.97 CHF, with a previous close of 10.90 CHF. The stock has fluctuated within a day range of 10.57 CHF to 11.05 CHF, while its 52-week range spans from 3.92 CHF to 11.25 CHF.

What Is DocMorris (DOCM) Price Target According to Analysts?

The average 12-month price target for DocMorris is 11.15 CHF, with a high estimate of 13.6 CHF and a low estimate of 9.6 CHF. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +1.64% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.